-+ 0.00%
-+ 0.00%
-+ 0.00%

*Organon Acquires From Biogen U.S. Regulatory and Commercial Rights for Tofidence, a Biosimilar to Actemra, for Intravenous Infusion >OGN

Dow Jones·04/01/2025 11:31:00

Please log in to view news